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Aim To assess the seven-year trends of hospitalization in-
cidence due to acute peptic ulcer hemorrhage (APUH) 
and associated risk factors, and examine the differences in 
these trends between two regions in Croatia.
Methods The study collected sociodemographic, clinical, 
and endoscopic data on 2204 patients with endoscopical-
ly confirmed APUH who were admitted to the Clinical Hos-
pital Center “Sestre Milosrdnice,” Zagreb and Clinical Hos-
pital Center Split between January 1, 2005 and December 
31, 2011. We determined hospitalization incidence rates, 
30-day case fatality rate, clinical outcomes, and incidence-
associated factors.
Results No differences were observed in APUH hospital-
ization incidence rates between the regions. Age-stan-
dardized one-year cumulative APUH hospitalization in-
cidence rate calculated using the European Standard 
Population was significantly higher in Zagreb than in Split 
region (43.2/100 000 vs 29.2/100,000). A significantly high-
er APUH hospitalization incidence rates were observed in 
the above 65 years age group. Overall 30-day case fatality 
rate was 4.9%.
Conclusion The hospitalization incidence of APUH in two 
populations did not change over the observational period 
and it was significantly higher in the Zagreb region. The 
incidence of acute duodenal ulcer hemorrhage also re-
mained unchanged, whereas the incidence of acute gas-
tric ulcer hemorrhage increased. The results of this study 
allow us to monitor epidemiological indicators of APUH 
and compare data with other countries.
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Acute peptic ulcer hemorrhage (APUH) is a common med-
ical condition that results in high patient morbidity. In spite 
of pharmacological and endoscopic therapy advance-
ments, APUH remains a significant medical problem due 
to still unresolved questions regarding acute management 
and complications (1). Mortality rates from ulcer hemor-
rhage in various European countries range from 3.4% to 
14%, and the reason for this difference is unknown (1-3). 
While the prevalence of H. pylori infection declines, there is 
an increase in the proportion of patients with ulcer hemor-
rhage unrelated to H. pylori infection or the use of non-ste-
roidal anti-inflammatory drugs (NSAIDs), including aspirin 
(4). Recent data suggest that patients with non-H. pylori-
non-NSAID idiopathic bleeding peptic ulcers have signif-
icantly higher mortality rates than patients with H. pylori 
ulcers (5). Numerous studies have shown that endoscopic 
and pharmacological treatment of APUH episodes can re-
duce rebleeding rates, rates of surgical interventions, and 
length of hospital stay, although some trials indicate that 
none of these approaches has substantially reduced the 
overall mortality associated with bleeding events (3,4,6). So 
far no data has been published on the hospitalization inci-
dence of APUH in Croatia. The aim of this study was to as-
sess the seven-year trends in hospitalization incidence due 
to APUH, clinical features of APUH, and 30-day case fatality 
in two different regions in Croatia.
MeTHoDs
This study was conducted in two centers that together 
serve a population of approximately 760 000: Clinical Hos-
pital Center “Sestre Milosrdnice” in Zagreb – northern re-
gion of Croatia, serving a population of 300 000 people 
and Clinical Hospital Center Split – southern region of Cro-
atia, serving a population of 460 000 people. 4571 consec-
utive patients admitted to these centers with acute upper 
gastrointestinal hemorrhage between January 1, 2005 and 
December 31, 2011 were considered for inclusion. Only the 
first admission of each patient was counted, irrespective of 
subsequent or previous episodes of upper gastrointestinal 
hemorrhage. Acute upper gastrointestinal hemorrhage 
was suspected if the patient presented with hematemesis, 
melena, or hematochezia and/or if bloody nasogastric as-
pirate was observed. In all such patients, upper gastroin-
testinal endoscopy was performed within 12 hours of hos-
pital admission. Patients were included in the study only 
if emergency endoscopy revealed a gastric or duodenal 
ulcer without any other source of bleeding. The follow-
ing patients’ data were collected: sex, age, smoking and 
alcohol consumption, recent use of NSAIDs and/or 
antiplatelet agents (aspirin, clopidogrel, and ticlopidine), 
medical history, and physical and initial laboratory findings 
(complete blood count, prothrombin time, and renal func-
tion tests). Drug usage was defined as at least one dose 
taken within one week before the episode of hemorrhage. 
The overall health and comorbidity was graded according 
to the American Society of Anesthesiology (ASA) classifica-
tion (7). The hemodynamic instability was defined as syn-
cope or systolic blood pressure <100 mm Hg. Risk assess-
ment of APUH was performed according to the Rockall 
classification (8).
Endoscopy was carried out by trained endoscopists, 
each with at least five years of experience in treating pa-
tients with gastrointestinal (GI) hemorrhage. Endoscop-
ic characteristics including ulcer localization, ulcer size, 
and signs of hemorrhage were recorded. The diameter 
of ulcer was measured using endoscopic biopsy forceps 
(FG-25K, Olympus, Tokyo, Japan). Hemorrhage was clas-
sified according to the modified Forrest criteria (9). The 
commonly used hemostatic procedures were epineph-
rine injection (1:10 000 solution of epinephrine) and/or 
mechanical hemostasis with stainless steel hemoclips 
(Olympus). All patients were given acid suppressive ther-
apy: pantoprazole 80 mg i.v. (bolus) and then 40 mg i.v. 
every 8 hours for at least 48 hours, followed by 40 mg dai-
ly orally, or esomeprazole 80 mg i.v. (bolus), and then 40 
mg 15 i.v. every 8 hours for at least 48 hours, followed by 
40 mg daily orally. Primary hemostasis was defined as ab-
sence of hemorrhage immediately after the initial endo-
scopic hemostasis, whereas permanent hemostasis was 
defined as the absence of recurrent bleeding within the 
30-day period after the initial or secondary endoscopic 
hemostasis. Recurrent bleeding was defined as one or 
more signs of ongoing hemorrhage, including fresh he-
matemesis or melena, hematochezia, aspiration of fresh 
blood via nasogastric tube, and hemoglobin level de-
crease by more than 2 g/dL over a 24-hour period. If re-
current hemorrhage was suspected, upper endoscopy 
was performed immediately. Recurrent hemorrhage was 
confirmed in case of active bleeding, presence of fresh 
blood clot in the ulcer base or “coffee ground” material or 
blood in the stomach and/or duodenum. Patients with 
two unsuccessful endoscopic retreatments underwent 
emergency surgery.
Gastric biopsies for H. pylori diagnosis were performed in 
1932 patients (87.6%) during index endoscopy. Two biopsy 
specimens were taken from the gastric antrum and body, 
and the presence of H. pylori was assessed by histologic 
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examination of the specimens using hematoxylin-eosin 
(HE) stain. In patients with gastric ulcer without recurrent 
bleeding, control endoscopy was performed 4-5 days af-
ter the initial hemostasis, and biopsy specimens were ob-
tained from the margins and the base of gastric ulcers to 
exclude malignancy. Patients with suspected or proven 
malignancy (n = 56) were not included in the study. In both 
gastric and duodenal ulcer patients with negative H. pylori 
histology at index endoscopy, urea-breath test or control 
endoscopy with histology was performed following cessa-
tion of acid suppressive therapy for at least 2 weeks.
Clinical outcome was recorded for up to 30 days and was 
defined as the amount of red blood cell transfusion, need 
for surgical intervention, days of hospitalization, and 30-
day mortality. Written informed consent was obtained be-
fore endoscopy and enrollment. Ethical approval was ob-
tained from ethics committees of both hospitals.
TABLe 1. Age-standardized hospitalization incidence rates per 100 000 population for gastric and duodenal peptic ulcers hemorrhage using the 




in this study* population* age-specific age -standardized
participants 
in this study*population* age-specific age-standardized
Men
<65 years, n 368 781,747  47 315,3963 365 1,260,909  29 1,939,473
65-80 years, n 237 144,627 164 1,474,825 302 230,284 131 1,180,282
≥80 years, n  67 31,856 210 420,643  99 54,174 183 365,491
overall crude incidence 
(95% confidence interval)
70.1 (64.8-75.4) 49.6 (46.1-53.1)
overall age standardized 
incidence†
64.7 (59.8-69.6) 44.7 (41.5-47.8)
Rate ratio Zagreb vs split 1.41




<65 years, n 127 864,603  15 984,151  69 1,269,573   5 364,138
65-80 years, n 164 205,975  80 716,590 155 296,055  52 471,197
≥80 years, n 100 71,191 140 280,933 121 109,005 111 222,007
overall crude incidence 
(95% confidence interval)
34.2 (30.9-37.6) 20.6 (18.4-22.8)
overall age standardized 
incidence (95% confi-
dence interval)†
25.4 (22.9-27.9) 13.6 (12.1-15.0)
Rate ratio Zagreb vs split 1.66




<65 years, n 495 1,646,343  30 2,014,464 464 2,530,482  18 1,228,540
65-80 years, n 401 350,606 114 1,029,361 457 526,339  87 781,436
≥80 years, n 167 103,050 162 324,115 220 163,179 135 269,642
overall crude incidence 
(95% confidence interval)
50.6 (47.6-53.7) 35.4 (33.4-37.5)
overall age standardized 
incidence (95% confi-
dence interval) †
43.2 (40.6-45.8) 29.2 (27.5-30.9)
Rate ratio Zagreb vs split 1.42




†Age-standardized rates per 100 000 population for specific age groups calculated using the european standard Population. All differences were significant 
(P < 0.05) in favor of the Zagreb region.
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statistical analysis
All analyses were performed with the statistical pack-
age STATISTICA, version 10, (www.statsoft.com). The total 
population of Zagreb and Split covered by the two stud-
ied hospitals according to data from 2005 was used as 
the standard. Crude age-specific rates were determined 
for each region for both sexes and for total sample. Direct 
standardization using European standard population from 
2013 was performed for all crude rates, and adequate rate 
ratios were determined. Distribution of the European Stan-
dard Population for our study was 67 000 for age group 
15-65 years, 9000 for age group 65-79 years, and 2000 for 
age group older than 80 years (10). Confidence intervals 
(CI) were used to present differences between the groups 
The age-standardized rate for a particular condition (gas-
tric or duodenal ulcer bleeding) was obtained by applying 
the observed age-specific rates for the condition to a given 
standard population.
ResuLTs
Data on 2204 patients with endoscopy-confirmed APUH 
were analyzed, yielding a one-year cumulative age-stan-
dardized hospitalization incidence of 41.4 cases/100 000 
people (95% CI, 39.7-43.2). Age-standardized one-year 
TABLe 2. Clinical characteristics of the patients with acute peptic ulcer hemorrhage from Zagreb and split region
Gastric ulcer Duodenal ulcer
Zagreb split P Zagreb split P
No. patients, n (%) 596 (56.1) 466 (43.9) 467 (40.9) 675 (59.1)
Age (years), n (%):
<65 239 (40.1) 164 (35.2) 256 (54.8) 300 (44.5)
65-80 262 (44.0) 207 (44.4) 0.102 139 (29.8) 250 (37.0) 0.003
>80  95 (15.9)  95 (20.4)  72 (15.4) 125 (18.5)
sex, n (%):
Men 345 (57.9) 299 (64.2) 0.038 327 (70.0) 497 (73.6) 0.181
Women 251 (42.1) 167 (35.8) 140 (30.0) 178 (26.4)
Clinical presentation, n (%):
Gastric content
blood 234 (39.3) 191 (41.0) 0.569 213 (45.6) 302 (46.0) 0.772
coffee ground 362 (60.7) 275 (59.0) 254 (54.3) 373 (54.0)
Hemodynamic instability  59 (9.2)  12 (2.6) <0.001  56 (12.0)   4 (0.6) <0.001
Rockall score
<3 167 (28.0) 275 (59.0) 174 (37.3) 425 (63.0)
3-6 358 (60.1) 181 (38.8) <0.001 252 (53.9) 241 (35.7) <0.001
≥7  71 (11.9)  10 (2.2)  41 (9.8)   9 (1.3)
Hemoglobin level (g/L), mean ± standard deviation  93.2 ± 25.2  93.9 ± 24.1 0.706  95.1 ± 24.7  93.6 ± 26.6 0.341
overall comorbidities, n (%):
Mild disease (ASA 2) 142 (23.8) 220 (47.2) <0.001 104 (22.3) 282 (41.8) <0.001
Moderate/Severe (ASA 3-4) 174 (29.2) 141 (30.3) 0.706 102 (21.8) 167 (24.7) 0.256
H. pylori [positive/n (%)] 259/673 (38.5) 95/264 (36.0) 0.478 212/452 (46.9) 275/543(50.6) 0.240
Drugs on presentation, n (%):
NSAIDs 251 (42.1)  78 (16.7) <0.001 162 (34.7) 118 (17.5) <0.001
Aspirin  75 (12.6) 121 (26.0) <0.001  59 (12.6) 141 (20.9) <0.001
Antiplatelet drugs  14 (2.4)   0 (0) 0.001  13 (2.8)   0(0) <0.001
Corticosteroids   4 (0.7)   1 (0.2) 0.076   4 (0.9)   3 (0.4) 0.380
Anticoagulants  30 (5.0)  36 (7.7) 0.072  15 (3.2)  41 (6.1) 0.028
History, n (%):
Alcohol consumption 155 (26.0)  75 (16.1) <0.001 134 (28.7)  84 (12.4) <0.001
Smoking 163 (27.4)  70 (15.0) <0.001 151 (32.3) 103 (15.3) <0.001
Previous ulcer disease 168 (28.2) 106 (22.8) 0.044 161 (34.5) 244 (36.2) 0.561
Previous ulcer bleeding 130 (21.8)  87 (18.7) 0.203 126 (27.0) 150 (22.2) 0.065
*Abbreviation: NsAIDs – non-steroidal anti-inflammatory drugs; AsA – American society of Anesthesiologists.
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cumulative APUH hospitalization incidence rate calculat-
ed using the European Standard Population in Zagreb re-
gion was 43.2/100 000 (95% CI, 40.6-45.8) and it was sig-
nificantly higher than in Split region (29.2/100 000 [95% CI, 
27.5-30.9]) (Table 1). The incidence of acute duodenal ulcer 
hemorrhage remained unchanged during the study peri-
od, whereas the incidence for acute gastric ulcer hemor-
rhage increased (Figure 1).
The majority of patients with APUH were men (66.6%, Table 
2). The annual changes of the number of cases with acute 
gastric and duodenal ulcer hemorrhage for both sexes are 
shown in Figure 2 and Figure 3, respectively.
A slight increase in the mean age of patients with APUH 
was observed in the study period (62.9 to 65.1 years) and 
the proportion of patients older than 65 years increased 
TABLe 3. endoscopic characteristics and clinical outcome of the patients with acute peptic ulcer hemorrhage from Zagreb and split 
region
Gastric ulcer Duodenal ulcer
Zagreb split P Zagreb split P
No. patients, n (%) 596 (56.1) 466 (43.9) 467 (40.9) 675 (59.1)
signs of hemorrhage, n (%):
spurting  32 (5.4)  22 (4.7) 0.607  31 (6.6)  16 (2.4) <0.001
oozing  67 (11.3)  45 (9.7) 0.559  76 (16.3)  94 (13.9) 0.350
Visible vessel 148 (25.0)  29 (6.2) <0.001  79 (16.9)  31 (4.6) <0.001
Adherent clot  90 (15.2)  65 (14.0) 0.647  88 (18.8) 115 (17.0) 0.385
Pigmented spot  99 (16.7)  47 (10.1) 0.001  66 (14.1)  61 (9.0) 0.008
Clean base ulcer 157 (26.5) 258 (55.4) <0.001 127 (27.2) 358 (53.0) <0.001
ulcer size, n (%):
<2 cm 500 (84.2) 335 (79.2) <0.001 420 (90.1) 517 (76.6) <0.001
≥2 cm  94 (15.8) 131 (28.1)  46 (9.9) 158 (23.4)
endoscopic therapy, n (%) 323 (54.2) 156 (33.5) <0.001 257 (55.3) 241 (35.7) <0.001
Initial hemostasis, n (%) 320 (95.0) 144 (89.4) 0.02 256 (93.4) 217 (84.8) 0.001
Recurrent hemorrhage, n (%)  44 (7.4)  27 (5.8) 0.304  53 (11.4)  63 (9.3) 0.257
emergency surgery, n (%)  23 (3.9)  18 (3.9) 0.998  38 (8.1)  21 (3.1) <0.001
30-day mortality, n (%)  28 (4.7)  28 (6.0) 0.343  21 (4.5)  32 (4.7) 0.847
Blood transfusion (mL), median (range) 780 (270-2540) 740 (140-3460) 0.019 810 (290-4270) 960 (190-5460) 0.006
Hospital stay (days), median (range)   7 (1-45)   7 (1-27) 0.990   7 (1-30)   6 (1-24) 0.342
FIGuRe 1. Hospitalization incidence of gastric and duodenal 
ulcer hemorrhage during the seven-year period (2005-2011) in 
two regions in Croatia
FIGuRe 2. Hospitalization incidence of gastric ulcer hemor-
rhage in men and women during the seven-year period (2005-
2011) in two regions in Croatia
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from 33.3% in 2005 to 48.7% in 2011. Patients from Zagreb 
region more often smoked, consumed alcohol, and used 
NSAIDs. The prevalence of H. pylori infection, rebleeding 
rate, and 30-day case-fatality rate were similar in Zagreb 
and Split region.
Endoscopic intervention was performed in 977 patients 
(44.3%), with initial hemostasis achieved in 91.7% of cas-
es (Table 3). Initial hemostasis during endoscopic inter-
vention was achieved more frequently in Zagreb region 
(94.3% vs 86.6%), as well as mechanical hemostasis with 
hemoclips (39.2% vs 19.4%). The overall rebleeding rate 
was 18.2% (187 patients with successful initial endoscopic 
hemostasis).
One hundred patients (4.5%) underwent surgery due to 
either continuing (12 patients) or recurrent bleeding (83 
patients), and perforation (5 patients). More patients were 
transferred to surgery in Zagreb than in Split region (5.7% 
vs 3.4%). The majority of patients in whom emergency sur-
gery was performed (59%) had duodenal ulcer located on 
the posterior wall of the duodenal bulb. Over-sewing of 
the bleeding vessel (61/100 patients) and partial gastrecto-
my (37/100 patients) were the most frequent operations.
The overall 30-day case-fatality rate was 4.9%. The rate was 
similar for patients treated conservatively and those treat-
ed surgically (4.5 vs 6.0%), and one-year cumulative mor-
tality rate remained unchanged during the study period. 
Mortality was higher in patients older than 65 years and in 
patients with in-hospital hemorrhage recurrence and se-
vere comorbidities. The cause of death in 39.8% patients 
were severe underlying comorbid illnesses, most common 
being ischemic heart disease, malignancy, cerebrovascular 
accidents, and cirrhosis.
DIsCussIoN
Although the introduction of effective antisecretory drugs, 
alongside H. pylori eradication therapies, dramatically im-
proved APUH treatment, the hospitalization incidence 
of APUH in two regions in Croatia did not change in the 
study period. In the majority of developed countries, hos-
pitalization rates for APUH are steadily decreasing (11,12), 
although some studies from England and Finland report 
an increase (13,14). Concurrently, consumption of aspirin 
or NSAIDs is increasing, particularly among the elderly pa-
tients (15). This is consistent with our data demonstrating 
a significant increase in the proportion of elderly patients 
with peptic ulcer bleeding, with a high proportion of pa-
tients who were taking NSAIDs. Our study found that the 
hospitalization for peptic ulcer hemorrhage per 100 000 re-
mained unchanged, which is similar to Danish and Dutch 
studies (16,17).
In Western countries in the second half of the 20th century 
peptic ulcer was no longer a disease predominant in men 
but had a comparable prevalence in both sexes (18). In our 
population, greater prevalence was observed in men.
There appears to be a considerable variation in the rates 
and pattern of peptic ulcer among different regions in 
the world, but there is a limited number of population-
based studies to support these conclusions (19). Zagreb 
is the largest city in Croatia situated in the northern part 
of the country, with predominantly continental European 
climate and typical central-European cuisine, whereas the 
Split is the largest city in the southern part of the country 
with Mediterranean climate and cuisine. These two cities 
are fairly good representatives of two different life styles. 
One-year cumulative hospitalization incidence for peptic 
ulcer bleeding was significantly higher in the northern part 
of Croatia. This finding can be explained by greater NSAID 
and tobacco consumption in northern Croatia, with no 
difference in H. pylori infection rates between the regions. 
The fact that the majority of APUH patients from northern 
Croatia had gastric ulcers additionally supports the role 
of these etiologic factors. Duodenal ulcers were more fre-
quent in the southern part of Croatia. Similar north-south 
differences in China and India have been attributed to re-
gional dietary habits (20,21).
FIGuRe 3. Hospitalization incidence of duodenal ulcer hemor-
rhage in men and women during the seven- year period 
(2005-2011) in two regions in Croatia
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Along with the significant increase in the proportion of 
elderly patients presenting with APUH, we observed that 
up to 52.2% of our patients had been exposed to drugs 
potentially harmful to the upper GI tract (NSAIDs, aspirin, 
antiplatelet agents, corticosteroids, and anticoagulants). 
At the same time, low percentage of gastroprotective 
drugs usage (up to 10%) was found in all age groups. This 
fact stresses the need for prescription of gastroprotec-
tive medications in elderly patients at high risk of upper 
GI bleeding.
The factors considerably affecting the rebleeding rate 
were hemodynamic instability upon admission, moderate 
to severe comorbidities, and the presence of duodenal ul-
cer larger than 2 cm in diameter with a spurting bleeding 
(5). Causes of mortality after APUH are more often related 
to cardiac or multiorgan failure than to the bleeding itself, 
particularly in older and co-morbid patients (22,23). The 
30-day case-fatality in our patients with APUH was 4.9%, 
which is in accordance with other similar studies (24-28).
In conclusion, the hospitalization incidence of APUH in two 
populations in Croatia did not change over a seven-year 
period and it was significantly higher in Zagreb region. The 
incidence of acute duodenal ulcer hemorrhage remained 
unchanged, whereas the incidence of acute gastric ulcer 
hemorrhage increased. The results of this study allow us to 
monitor epidemiological indicators of APUH and compare 
data with other countries.
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